Beta-Amyloid (17-40)

Overview

Beta-Amyloid (17-40) is a key peptide associated with Alzheimer’s disease, characterized by its presence in the plaques found in the brains of affected individuals. This peptide, along with its truncated counterpart beta-Amyloid 17-42, plays a significant role in the pathology of the disease. Research has linked these beta-Amyloid peptides to the induction of pro-inflammatory cytokines and chemokines, both in vitro and in vivo. If you’re studying Alzheimer’s disease or related neurodegenerative conditions, our Beta-Amyloid (17-40) peptide is an essential resource for your research.

Key Features

• Available in high purity, ideal for research applications.
• Linked to the production of pro-inflammatory markers, providing insights into Alzheimer’s pathology.
• Supports studies on neuroinflammation and neurodegenerative diseases.
• Compatible with various assay kits for enhanced detection and labeling.
• Reliable source for peptide synthesis and quality assurance.

Specifications

FAQ

What is Beta-Amyloid (17-40) used for?

This peptide is primarily used in research related to Alzheimer’s disease. It helps elucidate the mechanisms of plaque formation and neuroinflammation.

How should I store Beta-Amyloid (17-40)?

We recommend storing the peptide at -20°C to maintain its stability and integrity over time.

Can I use Beta-Amyloid (17-40) in my assays?

Yes, this peptide is compatible with various assay kits, such as the PKG Substrate and Autocamtide-2, enhancing your research capabilities.

For comprehensive study of neurodegenerative diseases, you may also explore our extensive range of peptides designed for complex biochemical applications. Each peptide, including Beta-Amyloid (17-40), provides a sound foundation for your experimental designs.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled